Validation and genomic interrogation of the MET variant rs11762213 as a predictor of adverse outcomes in clear cell renal cell carcinoma

  • A. Ari Hakimi
  • , Irina Ostrovnaya
  • , Anders Jacobsen
  • , Katalin Susztak
  • , Jonathan A. Coleman
  • , Paul Russo
  • , Andrew G. Winer
  • , Roy Mano
  • , Alexander I. Sankin
  • , Robert J. Motzer
  • , Martin H. Voss
  • , Kenneth Offit
  • , Mark Purdue
  • , Mark Pomerantz
  • , Matthew Freedman
  • , Toni K. Choueiri
  • , James J. Hsieh
  • , Robert J. Klein

Research output: Contribution to journal › Article › peer-review

17 Scopus citations

Fingerprint

Dive into the research topics of 'Validation and genomic interrogation of the MET variant rs11762213 as a predictor of adverse outcomes in clear cell renal cell carcinoma'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Biochemistry, Genetics and Molecular Biology

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience